We develop ultrasound-enabled micro-laboratories powered by simple batteries to serve the $50 billion in vitro diagnostic market.
Defineqa is a biotech startup developing low-powered, acoustic microfluidics for portable diagnostics. We have a patent-pending, platform technology that was originally developed at the University of California, Irvine with >$2 million of funding from DARPA and the NIH since 2007. At Defineqa, we are first developing, FitQA, a novel home test to monitor inflammation. This platform will be the foundation for many applications in digital health.